» Articles » PMID: 8806254

The Statistical Basis of Public Policy: a Paradigm Shift is Overdue

Overview
Journal BMJ
Specialty General Medicine
Date 1996 Sep 7
PMID 8806254
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The recent controversy over the increased risk of venous thrombosis with third generation oral contraceptives illustrates the public policy dilemma that can be created by relying on conventional statistical tests and estimates: case-control studies showed a significant increase in risk and forced a decision either to warn or not to warn. Conventional statistical tests are an improper basis for such decisions because they dichotomise results according to whether they are or are not significant and do not allow decision makers to take explicit account of additional evidence--for example, of biological plausibility or of biases in the studies. A Bayesian approach overcomes both these problems. A Bayesian analysis starts with a "prior" probability distribution for the value of interest (for example, a true relative risk)--based on previous knowledge--and adds the new evidence (via a model) to produce a "posterior" probability distribution. Because different experts will have different prior beliefs sensitivity analyses are important to assess the effects on the posterior distributions of these differences. Sensitivity analyses should also examine the effects of different assumptions about biases and about the model which links the data with the value of interest. One advantage of this method is that it allows such assumptions to be handled openly and explicitly. Data presented as a series of posterior probability distributions would be a much better guide to policy, reflecting the reality that degrees of belief are often continuous, not dichotomous, and often vary from one person to another in the face of inconclusive evidence.

Citing Articles

Quantitative decision making for investment in global health intervention trials: Case study of the NEWBORN study on emollient therapy in preterm infants in Kenya.

Stylianou A, Blanks K, Gibson R, Kendall L, English M, Williams S J Glob Health. 2022; 12:04045.

PMID: 35972445 PMC: 9185187. DOI: 10.7189/jogh.12.04045.


Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries.

Lilford R, Nepogodiev D, Chilton P, Watson S, Erlangga D, Diggle P BMJ Glob Health. 2021; 6(3).

PMID: 33737285 PMC: 7977070. DOI: 10.1136/bmjgh-2020-004723.


Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research.

Kumar A, Guss Z, Courtney P, Nalawade V, Sheridan P, Sarkar R JAMA Netw Open. 2020; 3(7):e2011985.

PMID: 32729921 PMC: 9009816. DOI: 10.1001/jamanetworkopen.2020.11985.


Buying a significant result: Do we need to reconsider the role of the P value?.

Jiroutek M, Rick Turner J J Clin Hypertens (Greenwich). 2017; 19(9):919-921.

PMID: 28548296 PMC: 8031103. DOI: 10.1111/jch.13021.


Public Response to Scientific Misconduct: Assessing Changes in Public Sentiment Toward the Stimulus-Triggered Acquisition of Pluripotency (STAP) Cell Case via Twitter.

Gayle A, Shimaoka M JMIR Public Health Surveill. 2017; 3(2):e21.

PMID: 28428163 PMC: 5418527. DOI: 10.2196/publichealth.5980.


References
1.
Eddy D, Hasselblad V, Shachter R . A Bayesian method for synthesizing evidence. The Confidence Profile Method. Int J Technol Assess Health Care. 1990; 6(1):31-55. DOI: 10.1017/s0266462300008928. View

2.
Lewis M, Spitzer W, Heinemann L, MacRae K, Bruppacher R, Thorogood M . Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ. 1996; 312(7023):88-90. PMC: 2349749. DOI: 10.1136/bmj.312.7023.88. View

3.
McPherson K . Third generation oral contraception and venous thromboembolism. BMJ. 1996; 312(7023):68-9. PMC: 2349743. DOI: 10.1136/bmj.312.7023.68. View

4.
Lilford R, Jackson J . Equipoise and the ethics of randomization. J R Soc Med. 1995; 88(10):552-9. PMC: 1295354. View

5.
Buring J, Glynn R, Hennekens C . Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA. 1995; 274(8):654-5. View